We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Ultrasound Machine Expands POC Possibilities

By HospiMedica International staff writers
Posted on 10 Nov 2021
A new ultrasound system with a slim cart and large screen helps technologists meet the diverse, evolving demands of point of care (POC) environments.

The Mindray Medical (Shenzen, China) TE7 Max Ultrasound System comes with a 21.5 inch vertically oriented high-definition (HD) LED display and a sealed touch-based interface. More...
A set of new comprehensive and customizable workflow protocols (iWorks) and an extensive suite of AI-powered Smart Tools are also offered. These include Smart B-Line, to enable rapid assessment of lungs; Smart VTI, to automatically locate the pulse wave (PW) Doppler sample line; transesophageal echocardiography (TEE) imaging; and Smart IVC, to assess volume status and fluid responsiveness in critically ill patients.

Other advanced applications include smart fetal heart rate (FHR) measurement during the first trimester; Smart Bladder for automatic calculation of bladder volume; and Auto EF, an intelligent way to analyze 2D echo clips by automatically recognizng diastolic and systolic blood pressure and ejection fraction during rapid clinical assessments at the patients' bedside. It is also equipped with an advanced suite of needle-guidance technologies (eSpacial Navi 4D Magnetic Needle Navigation and iNeedle+) to help streamline workflow and improve accuracy with needle-guided procedures.

“Five years ago, Mindray set a new standard for Point of Care ultrasound with the launch of the TE7. That System was truly ahead of its time, and today many of our competitors have tried to emulate,” said Maher Elhihi, senior director of marketing, ultrasound, at Mindray. “As a leader in Emergency Medicine ultrasound, it is our responsibility to push the technology forward, and the new TE7 Max raises the bar yet again and empowers our customers to provide the highest quality of care now and in the future.”

Point-of-care ultrasound (PoCUS) is an increasingly growing field that can be used in various clinical situations, including the intensive care unit (ICU) to monitor therapy, in the emergency department (ED) to exclude or include pathological findings, in physiological monitoring, such as hemodynamic assessment, preload, cardiac function (LVF and RVF), afterload, and volume status, evaluation of the abdomen, gynecological or obstetric monitoring, or even in preclinical settings.

Related Links:
Mindray Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Syringe Pump
SP50 Series
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.